The Food and Drug Administration (FDA) issued a public warning about compounded topical versions of a popular hair loss drug sold through telehealth platforms. However, the agency has not approved any ...

The FDA is warning about a topical spray version of finasteride, a drug often sold online by telehealth companies. Adobe stock/HealthDay A quick spray of medication might seem like an easy way to get ...

The Food and Drug Administration on Tuesday posted a warning about generic forms of a popular hair-loss medication often sold by major telehealth companies including Hims, Keeps and Ro, citing reports ...

The FDA issued a public alert on Tuesday concerning generic versions of a widely-used hair loss drug that is frequently distributed by popular telehealth brands like Hims and Keeps. The agency cited ...

A quick spray of medication might seem like an easy way to get thicker hair, but some people say one sold online has left them battling sexual side effects, depression and even thoughts of suicide.

Now, the U.S. Food and Drug Administration (FDA) is warning the public about the risks. (HealthDay News) — A quick spray of medication might seem like an easy way to get thicker hair, but some people ...